Skip to main content

Posts

Showing posts from August 3, 2025

Assessment of #serum #parameters caused by the #outbreak of #mycoplasma pneumoniae #pneumonia in #children after #COVID19

Abstract Mycoplasma pneumonia pneumonia(MPP) is a common respiratory disease that often occurs in children . The purpose of this study was to explore the clinical characteristics of children with mycoplasma pneumoniae pneumonia, the first outbreak after the prevalence of COVID-19 epidemic . Meanwhile, this study also analyzed the predictive value of serum protein indicators and coagulation parameters in the MPP group, as well as the correlation between these indicators. Children with Mycoplasma pneumoniae admitted to the pediatric ward of Chengdu Fifth People’s Hospital from May 2023 to March 2024 were selected. After screening, 411 children who met the research criteria were selected as the study subjects. All of the blood samples were tested for coagulation function , procalcitonin, serum protein and glucose among MPP group and control group. All data were processed for statistical analysis using GraphPad Prism 10.2.3. Comparison of the serum proteins and coagulation function between...

Venus Anadyomene, Titian (c.1520)

  Public Domain. Source: WikiArt,  https://www.wikiart.org/en/titian/venus-anadyomene _____

Impact of #COVID19 #vaccination #coverage on global #disability burden of #GBS

Abstract The global burden of Guillain-BarrĂ© syndrome (GBS), an immune-mediated neuropathy, remains poorly characterized during the COVID-19 pandemic . We analyzed age-standardized years lived with disability (YLD) for GBS from 1990 to 2021 using GBD 2021 data and COVID-19 vaccination coverage from Our World in Data, focusing on 2020–2021. During the pandemic, GBS YLD rates rose dramatically , with greater increases seen in low-SDI regions, females and individuals aged 15–29 years. Higher vaccination coverage was inversely associated with GBS disability burden , exhibiting a non-linear protective effect at moderate to high coverage levels. Causal mediation analysis indicated that 44.6% of this association was mediated by reductions in COVID-19 incidence, highlighting both direct and indirect neuroprotective benefits of vaccination programs . These results underscore the importance of sustaining and expanding the vaccine rollout to mitigate the secondary neurological burden associated w...